Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3678615011 | Product containing precisely erlotinib (as erlotinib hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3678617015 | Erlotinib (as erlotinib hydrochloride) 100 mg oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Erlotinib (as erlotinib hydrochloride) 100 mg oral tablet | Is a | Erlotinib only product in oral dose form | true | Inferred relationship | Some | ||
| Erlotinib (as erlotinib hydrochloride) 100 mg oral tablet | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Erlotinib (as erlotinib hydrochloride) 100 mg oral tablet | Is a | Erlotinib-containing product | false | Inferred relationship | Some | ||
| Erlotinib (as erlotinib hydrochloride) 100 mg oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
| Erlotinib (as erlotinib hydrochloride) 100 mg oral tablet | Has active ingredient | Erlotinib | false | Inferred relationship | Some | ||
| Erlotinib (as erlotinib hydrochloride) 100 mg oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Some | ||
| Erlotinib (as erlotinib hydrochloride) 100 mg oral tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Some | ||
| Erlotinib (as erlotinib hydrochloride) 100 mg oral tablet | Has active ingredient | Erlotinib hydrochloride | false | Inferred relationship | Some | ||
| Erlotinib (as erlotinib hydrochloride) 100 mg oral tablet | Has active ingredient | Erlotinib hydrochloride | false | Inferred relationship | Some | 1 | |
| Erlotinib (as erlotinib hydrochloride) 100 mg oral tablet | Has BoSS | Erlotinib | true | Inferred relationship | Some | 1 | |
| Erlotinib (as erlotinib hydrochloride) 100 mg oral tablet | Has presentation strength numerator value | 100 | false | Inferred relationship | Some | 1 | |
| Erlotinib (as erlotinib hydrochloride) 100 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Erlotinib (as erlotinib hydrochloride) 100 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Erlotinib (as erlotinib hydrochloride) 100 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 1 | |
| Erlotinib (as erlotinib hydrochloride) 100 mg oral tablet | Has active ingredient | Erlotinib | false | Inferred relationship | Some | ||
| Erlotinib (as erlotinib hydrochloride) 100 mg oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Some | ||
| Erlotinib (as erlotinib hydrochloride) 100 mg oral tablet | Has precise active ingredient | Erlotinib hydrochloride | true | Inferred relationship | Some | 1 | |
| Erlotinib (as erlotinib hydrochloride) 100 mg oral tablet | Is a | Erlotinib-containing product in oral dose form | false | Inferred relationship | Some | ||
| Erlotinib (as erlotinib hydrochloride) 100 mg oral tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR